XRCC1 polymorphism and overall survival in ovarian cancer patients treated with platinum-based chemotherapy: A systematic review and MOOSE-compliant meta-analysis

OBJECTIVES: Although platinum-based chemotherapy is widely used for advanced ovarian cancer (OC), genetic polymorphisms can influence the chemotherapeutic response. This study investigated the association between XRCC1 polymorphisms Arg194Trp, Arg280His, and Arg399Gln, and overall survival (OS) in O...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhuo, Xiang, Qian, Mu, Guangyan, Xie, Qiufen, Chen, Shuqing, Zhou, Shuang, Hu, Kun, Cui, Yi-min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250521/
https://www.ncbi.nlm.nih.gov/pubmed/30407287
http://dx.doi.org/10.1097/MD.0000000000012996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250521/
https://www.ncbi.nlm.nih.gov/pubmed/30407287
http://dx.doi.org/10.1097/MD.0000000000012996

Ejemplares similares